Advertisement
TTOO Новости Форекс
T2 Biosystems Says FDA Grants Breakthrough Device Designation For T2Lyme Panel
T2 Biosystems, Inc. (TTOO) announced Monday the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Company's T2Lyme Panel.
RTTNews
|
1064 дней спустя
